Eli Lilly’s Diabetes Shot Mounjaro Wins FDA Nod For Heart Disease
Story updates
11:00:38 AM UTC
SquawkNews
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
11:00:58 AM UTC
SquawkNews
LLY - FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
11:10:33 AM UTC
SquawkNews
Eli Lilly’s Diabetes Shot Mounjaro Wins FDA Nod For Heart Disease
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.